Insider Transactions in Q4 2018 at Moderna, Inc. (MRNA)
Insider Transaction List (Q4 2018)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 11
2018
|
Lorence H. Kim Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct |
458
+0.04%
|
-
|
|
Dec 11
2018
|
Stephane Bancel Chief Executive Officer |
BUY
Conversion of derivative security
|
Indirect |
13,830,496
+14.43%
|
-
|
|
Dec 11
2018
|
Afeyan Noubar |
BUY
Conversion of derivative security
|
Indirect |
47,343,020
+26.74%
|
-
|
|
Dec 11
2018
|
Stephen Berenson Director |
BUY
Conversion of derivative security
|
Direct |
22,798
+50.0%
|
-
|
|
Dec 11
2018
|
Israel Ruiz Director |
BUY
Conversion of derivative security
|
Direct |
4,559
+50.0%
|
-
|
|
Dec 11
2018
|
Paul Sagan Director |
BUY
Conversion of derivative security
|
Indirect |
367,776
+50.0%
|
-
|
|
Dec 11
2018
|
Robert Langer Director |
BUY
Conversion of derivative security
|
Direct |
4,559
+0.04%
|
-
|
|
Dec 11
2018
|
Elizabeth G Nabel Director |
BUY
Conversion of derivative security
|
Direct |
13,679
+23.58%
|
-
|
|
Dec 11
2018
|
Stephen Hoge President |
BUY
Conversion of derivative security
|
Direct |
458
+0.02%
|
-
|